Among the six tumor markers included in our study, CEA and CA15-3 were mostly demonstrated and their elevated levels were closely related to poor prognosis in breast cancer patients [17, 20, 22, 23, 38]. This evidence concerns the gene CEACAM5 and neoplasm.